Key points are not available for this paper at this time.
Abstract Non-small cell lung cancer (NSCLC) remains a prevalent and deadly malignancy, presenting a substantial global health challenge. Significant progress has been achieved in the last few decades regarding the comprehension of the complex molecular mechanisms that underlie NSCLC. This extensive literature review analyzes the present understanding of the molecular pathways associated with non-small cell lung cancer (NSCLC) and emphasizes the potential of molecular targeting as a favorable therapeutic approach. We conduct a detailed analysis of key molecular targets and discuss the impact of emerging therapeutic modalities on the treatment landscape of NSCLC. Furthermore, we explore potential avenues for future research in this rapidly advancing field, emphasizing the importance of ongoing research and innovation in managing NSCLC and advancing precision medicine.
Rosas et al. (Thu,) studied this question.